Invesco
RCEL icon

Invesco’s Avita Medical RCEL Stock Holding History

Invesco’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,011
Closed -$58.2K – 3844
2025
Q2 		$58.2K Buy
11,011
+39
+0.4% +$284 ﹤0.01% 3711
2025
Q1 		$89.3K Sell
10,972
-678
-6% -$6.33K ﹤0.01% 3640
2024
Q4 		$149K Buy
11,650
+220
+2% +$2.6K ﹤0.01% 3567
2024
Q3 		$123K Buy
11,430
+452
+4% +$4.25K ﹤0.01% 3591
2024
Q2 		$86.9K Buy
10,978
+4
+0% +$38 ﹤0.01% 3770
2024
Q1 		$176K Sell
10,974
-17,427
-61% -$282K ﹤0.01% 3672
2023
Q4 		$390K Sell
28,401
-4,491
-14% -$51.5K ﹤0.01% 3339
2023
Q3 		$481K Sell
32,892
-144,135
-81% -$2.44M ﹤0.01% 3221
2023
Q2 		$3.01M Buy
177,027
+25,533
+17% +$375K ﹤0.01% 2486
2023
Q1 		$2.12M Buy
+151,494
New +$1.61M ﹤0.01% 2608

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invesco's RCEL Position: Q3 2025 in Review

Invesco sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 11,011 shares — an estimated $58.2K sold.

Invesco first reported a position in RCEL in Q1 2023 and held it in 10 quarters. The position peaked at $3.01M in Q2 2023. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Invesco reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Invesco sold 11,011 Avita Medical shares in Q3 2025, an estimated $58.2K.
  • Invesco first reported a position in Avita Medical in Q1 2023 and held it in 10 quarters.
  • Invesco's Avita Medical position peaked at $3.01M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Invesco's 13F filing for Q3 2025, filed 13 Nov 2025.